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Abstract 
This DiB article contains data related to the research article entitled “Cellular responses to 
thermoresponsive stiffness memory elastomer nanohybrid scaffolds by 3D-TIPS” [1]. 
Thermoresponsive poly (urea-urethane) nanohybrid elastomer (PUU-POSS) scaffolds were 
implanted in rats for up to 3 months. The porous structure and tensile mechanical properties of 
the scaffolds are listed and compared before and after in vitro and in vivo tests.  The details of 
histological analysis of the explants with different initial stiffness and porous structures at 
various time points are presented. The images and data presented support the conclusion about 
the coupled effects of stiffness softening and the hierarchical porous structure modulating tissue 
ingrowth, vascularization and macrophage polarization the article [1]. 
 
Specifications Table 
Subject area Chemistry, Biology 
More specific subject 
area 
Biomaterials 
Type of data Tables, Figures 
How data was acquired Static tensile mechanical testing (Instron5655), Mercury intrusion 
porosimeter (Quantachrome Poremaster 60GT), XRD (Bruker D8 
Advance), immunohistochemistry  
Data format Analyzed 
Experimental factors Scaffolds prior to implantation were subjected to uniaxial mechanical 
testing and mercury intrusion porosimeter. Scaffold explants at 
different time points were subjected to uniaxial mechanical testing 
and XRD characterization. In addition, explants were sectioned and 
stained for Hematoxylin and Eosin (H&E) and Masson’s trichrome 
(M&T). Immunofluorescent staining was carried out to detect 
presence of capillary markers (i.e. CD31), macrophage markers (i.e. 
CD86, CD68, CD163) and T-cell makers (i.e. CD3, CD4).  
Experimental features Physico-mechanical characterization, histology and 
immunohistochemistry 
Data source location Centre for Biomaterials in Surgical Reconstruction and 
Regeneration, Division of Surgery & Interventional Science, 
University College London, Royal Free Hospital London NHS 
Foundation Trust, London, United Kingdom, NW3 2PF 
Data accessibility Within this article 
Related research article [1] L. Wu, A. Magaz, E. Maughan, N. Oliver, A. Darbyshire, M. 
Loizidou, M. Emberton, M. Birchall, W. Song, Cellular responses to 
thermoresponsive stiffness memory elastomer nanohybrid scaffolds 
by 3D-TIPS, Acta Biomater. (2018). 
doi:10.1016/j.actbio.2018.12.019.  
 
Value of the data  
 Data presented in this article provides direct comparison of the stiffness softening 
and hierarchical structure of the 3D-TIPS scaffolds before and after in vitro and in 
vivo tests. The data magnify more insights about the changes of structures at 
multi-scales and mechanical properties of the scaffolds under biophysical and 
biological conditions.  
 The histological images of the scaffolds with different initial stiffness and porous 
structure by immunohistochemistry elucidate for the first time how stiffness 
softening and digitally printed hierarchical porous structure regulate the tissue 
ingrowth, vascularization and macrophage polarization towards an M2 phenotype 
at the early (week 4) and late (week 12) stages in vivo. 
 
1. Data 
Table 1 shows the stiffness softening effect of the scaffolds in vitro over day 0-28 and how they 
relax towards their intrinsic elasticity. The dimensions of the 3D printed preforms and the  
scaffolds as produced are shown in Table 2. Tables 3-6 and Table 7 show the effects of 
softening during in vivo implantation at various time points, in terms of tensile mechanical 
properties and XRD characterization respectively. Figures 1-3 depict low and high 
magnification of Hematoxylin and Eosin (H&E) and Masson’s trichrome (M&T) staining 
showing collagen fibre orientation and tissue ingrowth within the explants. Table 8 quantifies 
the angiogenic response of the explants during implantation time with stiffness softening. The 
softening effects on macrophage polarization (M1 markers CD86, CD63 and M2 maker CD163) 
and T-cell response (markers CD3 and CD4) are quantified in Tables 9-15; representative 
immunohistochemistry images are shown in Figures 4-13. 
1.1 Static tensile mechanical properties and hierarchical porous structure of the scaffolds 
Table 1 Stiffness softening of PUU-POSS scaffolds with 50% infill density, tested at wet 
condition before and after in vitro incubation at 37  over 28 days. 
3D-TIPS 
scaffold, 50% 
infill 
Tensile 
Modulus (at 
50% strain) 
MPa 
Tensile 
Modulus (at 
100% 
strain) MPa 
Ultimate 
tensile 
strength 
(breaking 
point), MPa 
Strain at 
break, % 
Toughness, J. 
m
−3
×10
4
 
5
0
C
C
 Day 0 0.98 (±0.14) 0.82 (±0.21) 1.33 (±0.09) 179 (±8) 137 (±22) 
Day 28 0.45 (±0.08) 0.40 (±0.11) 0.77 (±0.15) 230 (±13) 115 (±20) 
5
0
C
C
+
H
 Day 0 0.53 (±0.02) 0.44 (±0.08) 0.76 (±0.05) 236 (±19) 113 (±27) 
Day 28 0.39 (±0.09) 0.32 (±0.08) 0.72 (±0.12) 240 (±18) 110 (±14) 
5
0
R
T
C
+
H
 
Day 0 0.44 (±0.06) 0.39 (±0.09) 0.67 (±0.03) 146 (±15) 146 (±12) 
Day 28 0.42 (±0.08) 0.38 (±0.10) 0.65 (±0.06) 149 (±19) 146(±20) 
 
Table 2 Dimensions of 3D-printed PVA preforms and PUU-POSS scaffolds made by 3D-TIPS 
Scaffold x- Strut 
thickness 
(µm, n=10） 
y-Strut 
thickness 
(µm, n=10） 
z-Strut 
thickness 
（µm, n=10） 
Sample Size, 
(L×W×T, mm) 
(n=6) 
Apparent 
Volume 
(mm
3
) 
Volume 
Swelling 
Ratio vs 
VPVA (%) 
50% infill PVA preform 
(mould) 
400 400 200 60.0×12.0×4.0 2880 ± 4  
50CC Wet, as 
produced, RT 
197±13 157±9 118±19 61.0×13.0×3.6 2855 ± 9 -0.9 ± 0.2 
50CC+H Wet, as 
produced, RT 
176±8 150±8 121±14 59.7×11.3×3.5 2361 ± 7 -18.0 ± 0.1 
50RTC+H Wet, as 
produced, RT 
186±10 140±11 127±10 58.9×12.7×3.9 2917 ± 13 1.2 ± 0.3 
 
 
 
 
 
 
  
Table 3 Tensile modulus (at 50% strain) of the scaffold explants at weeks 4, 8 and 12. 
Tensile modulus (MPa) 50CC 50CC+H 50RTC+H 
Week 0 1.11 (±0.13) 0.77 (±0.09) 0.43 (±0.08) 
Week 4 2.45 (±0.40) 2.13 (±1.38) 1.56 (±0.20) 
Week 8 3.99 (±0.55) 3.73 (±0.78) 3.13 (±0.88) 
Week 12 6.97 (±1.46) 6.08 (±1.35) 5.88 (±1.53) 
 
 
Table 4 Strain at break of the scaffold explants at weeks 4, 8 and 12. 
Strain at break (%) 50CC 50CC+H 50RTC+H 
Week 0 179 (±18) 186 (±19) 146 (±15) 
Week 4 340 (±24) 310 (±61) 291 (±70) 
Week 8 444 (±73) 423 (±71) 406 (±122) 
Week 12 521 (±70) 494 (±65) 454 (±80) 
 
Table 5 Ultimate tensile strength (breaking point) of the scaffold explants at weeks 4, 8 and 12. 
Ultimate tensile strength 
(MPa) 
50CC 50CC+H 50RTC+H 
Week 0 1.63 (±0.09) 0.99 (±0.05) 0.67 (±0.07) 
Week 4 1.07 (±0.39) 1.01 (±0.45) 0.81 (±0.18) 
Week 8 1.98 (±0.37) 1.86 (±0.53) 1.16 (±0.39) 
Week 12 2.84 (±0.53) 2.60 (±0.75) 2.44 (±0.29) 
 
Table 6 Toughness of the scaffold explants at weeks 4, 8 and 12. 
Toughness (J.m
-3 
10
4
) 50CC 50CC+H 50RTC+H 
Week 0 137 (±12) 146 (±12) 113 (±17) 
Week 4 412 (±24) 370 (±66) 351 (±79) 
Week 8 523 (±73) 463 (±81) 406 (±162) 
Week 12 599 (±99) 524 (±77) 444 (±90) 
  
 Table 7 Analysis of WAXD spectra of the explants during implantation. Degree of crystallinity 
(Dc, %), d-spacing (d, A) of semicrystalline structure and broad halo peaks of amorphous 
structures. 
Scaffolds Week 0 Week 4 Week e8 Week 12 
2  d Dc  2θ d Dc 2θ d Dc  2θ d Dc  
5
0
C
C
 
Sharp peak 1 20.0 4.4 37.6          
Sharp peak 2 23.2 3.8           
Broad halo peak 1             
Broad halo peak 2          20.1   
Broad halo peak 3    30.0   30.5   31.2   
Broad halo peak 4    40.5   41.5   41.9   
5
0
C
C
+
H
 
Sharp peak 1             
Sharp peak 2             
Broad halo peak 1             
Broad halo peak 2    19.2   19.2   20.0   
Broad halo peak 3 30.3   28.8   29.8   30.9   
Broad halo peak 4 41.3   42.1   42.2   42.2   
5
0
R
T
C
+
H
 
Sharp peak 1             
Sharp peak 2             
Broad halo peak 1             
Broad halo peak 2          19.3   
Broad halo peak 3 26.0   25.9   27.0   27.1   
Broad halo peak 4 42.3   42.0   42.7   41.6   
 
 1.2 Cellular infiltration and matrix deposition 
 
Figure 1 Hematoxylin & Eosin (H&E) stained histological structure of middle in-plane of 50CC 
scaffold explants at week 12 depicting tissue ingrowth within the scaffold network, ×2 
magnifications. 
  
Figure 2 Subcutaneous implantation of 50CC+H scaffolds at week 12: (A) tissue integration 
of middle-in-plane of the 50CC+H scaffold by Hematoxylin and Eosin (H&E) staining, (B) 
collagen production by Masson’s trichrome staining (M&T), (C) endothelial cell infiltration as 
identified by CD31 staining, used as a marker of angiogenesis; (D-F) enlarged views of middle-
in-plane respectively. (G-I) Middle cross-section view and (J-L) enlarged view. 
  
Figure 3 Subcutaneous implantation of 50RTC+H scaffolds at week 12: (A) tissue 
integration of middle-in-plane of the 50RTC+H scaffold by Hematoxylin and Eosin (H&E) 
staining, (B) collagen production by Masson’s trichrome staining, (C) endothelial cell infiltration 
as identified by CD31 staining, used as a marker of angiogenesis; (D-F) enlarged views of 
middle-in-plane respectively. (G-I) Middle cross-section view and (J-L) enlarged view. 
1.3 Angiogenesis response 
Table 8 Proportion of total tissue/scaffold volume occupied by blood capillaries at weeks 4, 8 
and 12. Immunofluorescent staining of anti-CD31 marker for blood capillaries. 
Capillary (%) 50CC 50CC+H 50RTC+H 
Week 4 11 (±1)  6 (±2)  3 (±2)  
Week 8 25 (±3)  12 (±4)  8 (±4)  
Week 12 30 (±4)  20 (±5)  14 (±5)  
 
  
1.4 T-cell proliferative and host macrophage response 
Table 9 Host pan-macrophage/monocyte response (CD68+ marker) towards the implanted 
scaffolds in terms of numerical density (Nv), representing the number of cells across the scaffold 
per unit square (Nv/mm
2
) at week 4, 8 and 12 (n=20 frames, 12 scaffolds in each group at each 
time point). 
CD68+ 50CC 50CC+H 50RTC+H 
Week 4 353 (±54)  301 (±56)  210 (±46)  
Week 8 322 (±48)  260 (±39)  164 (±48)  
Week 12 228 (±39)  201 (±43)  115 (±52)  
 
Table 10 Host macrophage response (CD86+ marker) towards the implanted scaffolds in terms 
of numerical density (Nv), representing the number of cells across the scaffold per unit square 
(Nv/mm
2
) at week 4, 8 and 12 (n=20 frames, 12 scaffolds in each group at each time point). 
CD86+ 50CC 50CC+H 50RTC+H 
Week 4 397 (±56)  289 (±47)  152 (±39)  
Week 8 312 (±55)  224 (±51)  132 (±45)  
Week 12 271 (±41)  186 (±55)  96 (±53)  
 
Table 11 Host macrophage response (CD163+ marker) towards the implanted scaffolds in terms 
of numerical density (Nv), representing the number of cells across the scaffold per unit square 
(Nv/mm
2
) at week 4, 8 and 12 (n=20 frames, 12 scaffolds in each group at each time point). 
CD163+ 50CC 50CC+H 50RTC+H 
Week 4 360 (±64)  294 (±65)  78 (±36)  
Week 8 531 (±88)  434 (±76)  103 (±67)  
Week 12 679 (±94)  534 (±78)  167 (±46)  
 
Table 12 Ratio of CD68+/ CD163+ of the various scaffold groups at weeks 4, 8 and 12. 
CD68+/CD163+ 50CC 50CC+H 50RTC+H 
Week 4 0.98 1.02  2.69 
Week 8 0.60  0.59  1.59  
Week 12 0.33  0.38  0.68 
 
 Table 13 Ratio of CD86+/ CD163+ of the various scaffold groups at weeks 4, 8 and 12. 
CD86+/CD163+ 50CC 50CC+H 50RTC+H 
Week 4 1.10 0.98 1.95 
Week 8 0.59 0.52 1.28 
Week 12 0.40 0.35 0.57 
 
Table 14 Host T lymphocyte response (CD3+ marker) towards the implanted scaffolds in terms 
of numerical density (Nv), representing the number of cells across the scaffolds per unit square 
(Nv/mm
2
) at week 4, 8 and 12 (n=20 frames, 12 scaffolds in each group at each time point). 
CD3+  50CC 50CC+H 50RTC+H 
Week 4 372 (±54)  301 (±56) 134 (±31)  
Week 8 232 (±48)  204 (±39)  67 (±15)  
Week 12 156 (±44)  109 (±43)  35 (±8)  
 
Table 15 Host T lymphocyte response (CD4+ marker) towards the implanted scaffolds in terms 
of numerical density (Nv), representing the number of cells across the scaffolds per unit square 
(Nv/mm
2
) at week 4, 8 and 12 (n=20 frames, 12 scaffolds in each group at each time point). 
CD4+ 50CC 50CC+H 50RTC+H 
Week 4 301 (±61)  245 (±71)  152 (±27)  
Week 8 252 (±42)  201 (±46)  102 (±28)  
Week 12 122 (±32)  87 (±45)  32 (±16)  
 
 
 
  
Figure 4 Immunohistochemistry of the host macrophage response towards scaffolds in vivo 
at week 4. Tissue integration of middle-in-plane (A-F) and cross-sectional view (G-L) of the 
scaffolds by CD68 (M1 pan-macrophage/monocyte marker) staining at (A-C, G-I) ×4 and (D-F, 
J-L) ×20 magnifications.  
  
Figure 5 Immunohistochemistry of the host macrophage response towards scaffolds in vivo 
at week 12. Tissue integration of middle-in-plane (A-F) and cross-sectional view (G-L) of the 
scaffolds by CD68 (pan-macrophage/monocyte marker) staining at (A-C, G-I) ×4 and (D-F, J-I) 
×20 magnifications. (M) Negative control (rat appendix); (N) positive control (rat liver). Scale 
bar: 100 μm. 
 
  
Figure 6 Immunohistochemistry of the host macrophage response towards scaffolds in vivo 
at week 4. Tissue integration of middle-in-plane (A-F) and cross-sectional view (G-L) of the 
scaffolds by CD86 (M1 macrophage marker) staining at (A-C, G-I) ×4 and (D-F, J-L) ×20 
magnifications.  
  
Figure 7 Immunohistochemistry of the host macrophage response towards scaffolds in vivo 
at week 12. Tissue integration of middle-in-plane (A-F) and cross-sectional view (G-L) of the 
scaffolds by CD86 (M1 macrophage marker) staining at (A-C, G-I) ×4 and (D-F, J-L) ×20 
magnifications. (M) Negative control (rat appendix); (N) positive control (rat liver). Scale bar: 
100 μm.  
  
Figure 8 Immunohistochemistry of the host macrophage response towards scaffolds in vivo 
at week 4. Tissue integration of middle-in-plane (A-F) and cross-sectional view (G-L) of the 
scaffolds by CD163 (M2 macrophage marker) staining at (A-C, G-I) ×4 and (D-F, J-L) ×20 
magnifications.  
  
Figure 9 Immunohistochemistry of the host macrophage response towards scaffolds in vivo 
at weeks 12. Tissue integration of middle-in-plane (A-F) and cross-sectional view (G-L) of the 
scaffolds by CD163 (M2 macrophage marker) staining at (A-C, G-I) ×4 and (D-F, J-L) ×20 
magnifications. (M) Negative control (rat appendix); (N) positive control (rat liver). Scale bar: 
100 μm.  
  
Figure 10 Immunohistochemistry of the host T lymphocyte response towards scaffolds in 
vivo at week 4. Tissue integration of middle-in-plane (A-F) and cross-sectional view (G-L) of 
the scaffolds by CD3 (T lymphocyte marker) staining at (A-C, G-L) ×4 and (D-F, J-L) ×40 
magnifications. 
  
Figure 11 Immunohistochemistry of the host T lymphocyte response towards scaffolds in 
vivo at week 12. Tissue integration of middle-in-plane (A-F) and cross-sectional view (G-L) of 
the scaffolds by CD3 (T lymphocyte marker) staining at (A-C, G-I) ×4 and (D-F, J-L) ×20 
magnifications. (M) Negative control (rat appendix); (N) positive control (rat spleen). Scale bar: 
100 μm. 
 
  
Figure 12 Immunohistochemistry of the host T lymphocyte response towards scaffolds in 
vivo at week 4. Tissue integration of middle-in-plane (A-F) and cross-sectional view (G-L) of 
the scaffolds by CD4 (T lymphocyte marker) staining at (A-C, G-I) ×4 and (D-F, J-L) ×20 
magnifications. 
 
 
  
Figure 13 Immunohistochemistry of the host T lymphocyte response towards scaffolds in 
vivo at week 12. Tissue integration of middle-in-plane (A-F) and cross-sectional view (G-L) of 
the scaffolds by CD4 (T lymphocyte marker) staining at (A-C, G-I) ×4 and (D-F, J-L) ×20 
magnifications. (M) Negative control (rat appendix); (N) positive control (rat spleen). Scale bar: 
100 μm. 
 
 
 
 2. Experimental Design, Materials and Methods 
2.1 Fabrication of thermoresponsive PUU-POSS scaffolds 
A 3D-TIPS technique, based on reverse 3D printing and phase separation of polymer solution, as 
described in [1], was used to manufacture PUU-POSS scaffolds (50% infill density) at different 
thermal conditions (50CC, 50CC+H and 50RTC+H). 
 
2.2 Characterization of the scaffolds prior to implantation 
An Instron 5655 was applied to test static tensile mechanical properties of the scaffolds, before 
and after incubation over 28 days at body temperature, as described in [1], as well the explants 
after implantation in rats for 4, 8 and 12 weeks. The dimensions of the printed preforms and the  
scaffold as produced were also measured and estimated.  
2.2 Characterization of the scaffold explants 
As detailed in [1], the scaffolds were subcutaneously implanted in adult male rats and harvested  
at different time points. The physico-mechanical properties (i.e. tensile properties and phase 
structure) were then analyzed with an Instron 5655 tester and an X-ray diffractometer. Sectioning 
and histological staining (i.e. H&E and M&T) were carried out, and collagen fiber formation and 
tissue ingrowth orientation was quantified as previously described [1]. Immunofluorescent 
staining against capillary marker CD31, macrophage markers CD86/CD68/CD163 and T-cell 
makers CD3/CD4 was carried out, and the number of positive stained cells was quantified as 
described in [1]. 
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